CHIOMA OBIUKWU: Open Payments
NPI 1891232005 · HAMILTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 86 payments from 17 companies in 2025. Trend: 2023 $1,766 · 2024 $1,377 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $181 |
| Janssen Pharmaceuticals, Inc | 6 | $112 |
| Alkermes, Inc. | 6 | $110 |
| Collegium Pharmaceutical, Inc. | 6 | $96 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| Vanda Pharmaceuticals Inc. | 5 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $62 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $57 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, Jornay PM, REXULTI, Auvelity, FANAPT, INVEGA SUSTENNA.
Industry payments across NJ — which companies pay providers there.
